Dimension Therapeutics Inc logo

DMTX - Dimension Therapeutics Inc News Story

$5.95 0.0  0.0%

Last Trade - 06/11/17

Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £11.9m
Position in Universe th / 6715

BRIEF-Ultragenyx to acquire Dimension Therapeutics

Tue 3rd October, 2017 1:30pm
Oct 3 (Reuters) - Ultragenyx Pharmaceutical Inc  RARE.O :  
    * Ultragenyx to acquire Dimension Therapeutics 
    * Ultragenyx Pharmaceutical Inc - deal for $6.00 per share 
    * Ultragenyx Pharmaceutical Inc - deal for approximately 
$151 million in cash 
    * Ultragenyx Pharmaceutical Inc - transaction is structured 
as a tender offer and will be funded through ultragenyx's 
existing cash resources 
    * Ultragenyx Pharmaceutical Inc - ultragenyx will pay 
regenxbio a termination fee pursuant to regenxbio merger 
agreement, on behalf of dimension 
    * Ultragenyx Pharmaceutical Inc - tender offer is not 
subject to a financing condition 
Source text for Eikon:  ID:nGNXOEQTHa  
Further company coverage:  RARE.O  
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.